we've got your back
Get started with Alongside™ KESIMPTA
For US residents only.
We’re closely monitoring the situation and want to make sure you’re staying safe. Please take precautions to reduce the risk of contracting COVID-19, and don’t hesitate to reach out to your health care team with questions or concerns.
You can also reach out to 1-888-NOW-NOVA (1-888-669-6682), 8:30 am–5:00 pm ET, Monday–Friday.
To learn more about how Novartis is responding to COVID-19, visit novartis.com/coronavirus.
We believe that treatment decisions should be made between you and your health care teams, so please do not stop taking KESIMPTA without talking to your neurologist or medical professional about any questions you may have.
Don’t make any changes to your medication routine that aren’t directed by your doctor. Otherwise, follow the general safety and hygiene guidelines from the experts at the Centers for Disease Control and Prevention, which include handwashing, social distancing, wearing a mask, and cleaning surfaces.
While the US Food and Drug Administration (FDA) has not made any specific warnings for people on immunosuppressant therapies as it relates to COVID-19 at the time this website was published, KESIMPTA is an immunosuppressant and may contribute to a higher risk or severity of infections because of its suppressive effect on the immune system. Every person has different risks and medical conditions.
It’s important to take precautions to reduce your risk of contracting COVID-19 and to seek medical care if you think you’ve been infected. Talk to your doctor or health care team about any concerns you have about your health.
At this time, we do not anticipate any disruption in product supply. We are confident that our existing stock is sufficient to cover production and distribution needs.
If you have concerns about your medication and COVID-19, please reach out to your health care team for further assistance.
While Novartis does not anticipate any supply shortages, the Centers for Disease Control and Prevention (CDC) advises people to get an extra supply of all essential medications. Reach out to your health care team or pharmacy to arrange this.
For more information about CDC recommendations for staying safe during this outbreak, visit cdc.gov/coronavirus/2019-ncov.
We understand these are trying times, and Novartis is committed to making your medication accessible and affordable. If your insurance plan is changing, or you are wondering about your copay, you can call Alongside™ KESIMPTA at 1-855-KESIMPTA (1-855-537-4678), 8:30 am–8:00 pm ET, Monday–Friday. We can help you figure out your options to help make KESIMPTA more affordable.
You could pay as little as $0 for your monthly KESIMPTA prescriptions through the copay program* if you have commercial or private prescription insurance. Click here or call 1-855-KESIMPTA (1-855-537-4678), 8:30 am–8:00 pm ET, Monday–Friday.
Get up to 12 months of KESIMPTA for free.* If you have commercial or private insurance and your prescription coverage isn’t initially approved, you may get up to 12 months of KESIMPTA for free through Alongside KESIMPTA while we work with your health care provider to try to secure coverage.
Visit the Novartis Patient Assistance Foundation, Inc. (NPAF), if you have limited or no prescription coverage or cannot afford your medication due to employment loss. You may be eligible to receive Novartis medications for free. Learn more at the Novartis Patient Assistance Foundation or by calling 1-800-277-2254.
We are committed to keeping the relapsing MS community up to date during this uncertain time. If there are any changes, we will reach out via phone/email. You can also follow KESIMPTA on Facebook to see the latest information.
We believe that treatment decisions should be made with your doctor. Every individual’s medical condition and history are different, and only your health care provider can decide what is right for you in light of COVID-19.
Be sure to call ahead before visiting your doctor. Keep in mind, some health care providers may have adopted phone or video chats (also called telemedicine) as a way to safely meet with patients.
For details regarding the COVID-19 pandemic and recommendations, visit the Centers for Disease Control and Prevention.